Article
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia.
Scientific reports - 10 Jan 2024
Seyoum Ayichew, Seyoum Berhanu, Gure Tadesse, Alemu Ashenafi, Alemayehu Dawit Hailu, Alemu Addisu, Belachew Anteneh, Tefera Dessalegn Abeje, Aseffa Abraham, Howe Rawleigh, Mulu Andargachew, Mihret Adane
Abstract excerpt
The World Health Organization [WHO] recommends a genotype-specific human papillomavirus [HPV] vaccination as a primary prevention strategy to control the burden of cervical cancer globally. In Ethiopia, where the non-vaccine-targeted HPV genotypes have not been adequately studied, a vaccination initiative was launched in 2018 targeting HPV-6,-11, -16, and -18 for girls aged 14-18 years. The co-existence of both...
Topics
Join the communities discussing this publication.
